Healthcare -
Biotechnology - NASDAQ - US
$ 3.53
-0.843 %
$ 32.6 M
Market Cap
-0.56
P/E
SABS - COST OF REVENUE
Cost of Revenue SABS - SAB Biotherapeutics, Inc.
3.75 M
LAST VALUE
50.50%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR